Menu
Subscribe - Individual
Subscribe - Biotech Premium (Corporate)
Home
About Us
Subscribe
Subscribe Individual
Subscribe Biotech Premium (Corporate)
Premium Biotech Coverage
Current News
Special Features
Company Index
Index Table
Summit
Summit History
20th Bioshares Biotech Summit
Contact
Contact Us
Email Alerts
Home
>
Premium Biotech Coverage
>
Current News
Current News
Categories
Categories
Acrux
Actinogen (ACW)
Aroa Biosurgery (ARX)
Blinklab (BB1)
Blog
Ceretas
Clever Culture Systems (CC5)
Clinuvel Pharmaceuticals (CUV)
Cogstate (CGS)
Cynata Therapeutics
Dimerix (DXB)
Imugene (IMU)
Neuren Pharmaceuticals (NEU)
Syntara (SNT) (previously Pharmaxis, PXS)
Uncategorized
October 16th, 2026
Syntara - Additional Positive Data Emerges from Early Parkinson's Disease Study
Read More
October 16th, 2026
Cogstate's Channel Partners Begin to Deliver
Read More
October 16th, 2026
Aroa Biosurgery - Positive Interim Results from Myriad Registry Study
Read More
October 16th, 2026
Acrux Confident of Partnering Deal for Female Testosterone Program
Read More
October 16th, 2026
Actinogen Medical - Phase II/III Alzheimer's Disease Trial Results Approaching
Read More
September 15th, 2026
Dimerix Accesses up to $34 Million in Debt Finance
Read More
September 15th, 2026
Strong Performance by Ceretas Following ASX Listing
Read More
September 15th, 2026
Clever Culture Systems Plan on Track, with Additional Sales to Novo Nordisk
Read More
September 1st, 2026
Clinuvel Considers ASX Delisting and Move to US Markets
Read More
September 1st, 2026
Summit Coverage: Diagnostic & Biomarkers Super Session
Read More
Pages
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
